
Glimwik PM 2mg/500mg/15mg Tablet
Marketer
Quria Healthcare
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimwik PM 2mg/500mg/15mg Tablet
Diabetic patients managing type 2 diabetes mellitus may find Glycemia-PM 2mg/500mg/15mg tablets beneficial. This triple-combination medication, used alongside diet and exercise, enhances blood glucose regulation by improving insulin utilization. Dosage and duration should strictly follow your physician's instructions. Always take it with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless the next dose is imminent; never double the dose. Excessive intake can cause hypoglycemia. Concurrent use with other antidiabetic medications, alcohol consumption, or skipped meals increases the risk of hypoglycemia. Regular blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Patients with kidney, liver, or heart conditions, or those who are pregnant or breastfeeding, must consult their doctor before commencing treatment. Kidney function tests are typically performed before initiating this medication. Limit alcohol consumption to mitigate potential side effects.
Uses of Glimwik PM 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glimwik PM 2mg/500mg/15mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the Glimwik PM 2mg/500mg/15mg tablet whole; avoid chewing, crushing, or fracturing it. Take this medication with food.
Common Side effects of Glimwik PM 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimwik PM 2mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Glimwik PM 2mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
How Glimwik PM 2mg/500mg/15mg Tablet works:
Glimwik PM 2mg/500mg/15mg tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when single or dual drug regimens prove inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood sugar. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, impeding intestinal glucose uptake, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glimwik PM 2mg/500mg/15mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimwik PM 2mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimwik PM 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Preliminary research in humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Glimwik PM 2mg/500mg/15mg tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. Avoid using Glimwik PM 2mg/500mg/15mg tablets in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimwik PM 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Glimwik PM 2mg/500mg/15mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimwik PM 2mg/500mg/15mg Tablet :
Should you forget a dose of Glimwik PM 2mg/500mg/15mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimwik PM 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes medication |
